Thermo Fisher Scientific Closes $3.8 Billion Offering of USD-Denominated Senior Notes

Thermo Fisher Scientific Closes $3.8 Billion Offering of USD-Denominated Senior Notes

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
We guide clients through today’s ever-changing debt markets, representing them in a broad variety of debt deals that range from complex financial structures to traditional loan transactions.

Thermo Fisher Scientific Inc. (NYSE, TMO) announced an offering of $3.8 billion aggregate principal amount of USD denominated senior notes, consisting of $1,000,000,000 aggregate principal amount of its 4.215% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 4.550% Senior Notes due 2033, $1,300,000,000 aggregate principal amount of its 4.902% Senior Notes due 2036, and $750,000,000 aggregate principal amount of its 5.546% Senior Notes due 2046. The offering priced on February 9, 2026, and closed on February 12, 2026. The joint book running managers for the offering were Deutsche Bank Securities Inc., RBC Capital Markets, LLC, SMBC Nikko Securities America, Inc., and Wells Fargo Securities, LLC.

WilmerHale advised Thermo Fisher on the transaction.

The WilmerHale team consisted of Molly Fox, Andrew Langworthy, Rachael Joseph, Amy O’Connell, and Madeline Gatto (Capital Markets), with assistance from Meghan Walsh and Skyler Dykes (Tax).

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel